Early virologic responses and hematologic safety of direct-acting antiviral therapies in veterans with chronic hepatitis C.
Clin Gastroenterol Hepatol
; 11(8): 1021-7, 2013 Aug.
Article
em En
| MEDLINE
| ID: mdl-23524130
Palavras-chave
APRI; BOC; Cirrhosis; DAA; HCV; ICD-9; International Classification of Diseases, 9th revision; OR; PEG; Protease Inhibitor; RBV; SVR; TVR; Therapy; VA; Veterans Affairs; aspartate aminotransferase/platelet ratio index; boceprevir; direct-acting antiviral; hepatitis C virus; odds ratio; pegylated interferon; ribavirin; sustained virologic response; telaprevir
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Antivirais
/
Hepatite C Crônica
/
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos
/
Anemia
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article